Company Quick10K Filing
Fluidigm
10-Q 2020-06-30 Filed 2020-08-07
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-27
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-03-18
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-03-08
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-03
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-04
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-12
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-12
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-26
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-28
8-K 2020-09-28 Enter Agreement
8-K 2020-09-08 Other Events
8-K 2020-08-06 Earnings, Exhibits
8-K 2020-06-23
8-K 2020-05-07
8-K 2020-05-05
8-K 2020-04-21
8-K 2020-04-14
8-K 2020-03-04
8-K 2020-02-10
8-K 2020-01-14
8-K 2019-11-20
8-K 2019-11-05
8-K 2019-08-01
8-K 2019-07-23
8-K 2019-06-03
8-K 2019-05-02
8-K 2019-04-18
8-K 2019-03-20
8-K 2019-02-27
8-K 2019-02-20
8-K 2019-02-13
8-K 2019-02-04
8-K 2018-12-11
8-K 2018-11-01
8-K 2018-10-30
8-K 2018-09-18
8-K 2018-08-02
8-K 2018-08-02
8-K 2018-07-30
8-K 2018-05-31
8-K 2018-05-03
8-K 2018-03-15
8-K 2018-03-12
8-K 2018-03-06
8-K 2018-03-02
8-K 2018-02-08
8-K 2018-02-06

Fluidigm Financials

FLDM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash10121481066596232203510144313437242929433632354440615842393695662628
Accounts Receivable109910101113101112111913172220222625201913151414141516171817191914
Inventory566677777881316171617191918201821202019181515151513141415
PP&E3334441755519912132814141434151717401514133411101032888
Assets8683797165117114113112114117425418410408395389378371354342320306292279292287270259252304291284269
Accounts Payable3544333323488766666465444545764785
Long-Term Debt131210300
Liabilities2323221916141313141721257256256257253256254256255258252253254255253256221224230232109111107
Stockholders' Equity6259575249103101100989796167162155150142133124115998468533924393149352272182173163
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue11111311131316151918212628303327292931292822252624252825262932302826
Cost of Revenue111111111122131312
Gross Profit283028272124242324262425171514
R&D33445444556811131210109101010999787777887
SG&A8889119111112121415221919202120222524212323212016191920232221
Tax00000000000-2-1-1-1-1-0-0-0-1-1-0-2-2-1-10-1-0-10-1-1
Net Income-7-4-3-7-5-4-4-4-4-4-5-15-13-14-11-16-15-9-13-20-19-20-18-17-17-16-10-13-16-15-25-14-13
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2-2-7-4-3-3-1-3-13-110-9-4-10-8-13-4-8-7-13-11-8-8-81-16-4-4-20-5-5
Cash Investing55575-22-28-1210-121-59-4610-718521010141840-4-041-10-367
Cash Financing-1-1-3-154-12112197111410000-0-00-0290-0-2-001-0